How we helped an established hemophilia player optimize its market access, pricing and reimbursement strategies in the US and EU5 markets.
The Challenge: How can an established player adapt its market access and…
How LucidQuest helped a company in the hemophilia space enhance its position in the market
The Challenge: How to unveil competitors' plans and gain a strategic edge A…
How LucidQuest insights helped a global leader in the Hemophilia space with its branding and positioning strategy.
The Challenge: To track the novel treatments’ (including gene and RNA…
Emerging trends in Hemophilia management. Is it time to say goodbye to standard CFC replacement therapy?
What is hemophilia? Hemophilia is a rare X-linked congenital bleeding disorder.…